Krishna VS, Zheng S, Rekha EM, Nallangi R, Sai Prasad D, George SE, Guddat LW, Sriram D. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.
Eur J Med Chem 2020;
193:112178. [DOI:
10.1016/j.ejmech.2020.112178]
[Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2019] [Revised: 02/12/2020] [Accepted: 02/20/2020] [Indexed: 01/17/2023]